Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Smith

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Science Advances|September 28, 2022
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning frameworkSabrina H Rossi, Izzy Newsham, Sara Pita, et al.
Minerva Ginecologica|July 29, 2020
Clinicopathological effects of body composition measurements for patients with endometrial cancerChristopher G Smith, Deepti Sharma, Hagen Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2015
Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of SurvivalChristopher G Smith, David Fisher, Rebecca Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studiesSabine Venderbosch, Iris D Nagtegaal, Tim S Maughan, et al.
EMBO Molecular Medicine|June 1, 2018
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerDana Wai Yi Tsui, Muhammed Murtaza, Alvin Seng Cheong Wong, et al.
EMBO Molecular Medicine|July 22, 2021
Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patientsFlorent Mouliere, Christopher G Smith, Katrin Heider, et al.
Lancet (London, England)|June 7, 2011
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialTimothy S Maughan, Richard A Adams, Christopher G Smith, et al.
EMBO Molecular Medicine|May 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancerAngela Santonja, Wendy N Cooper, Matthew D Eldridge, et al.
NPJ Breast Cancer|July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapyJesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Science Advances|July 10, 2026
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencingHaichao Wang, Paulius D Mennea, Grainne McAndrew, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Science Advances|September 28, 2022
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning frameworkSabrina H Rossi, Izzy Newsham, Sara Pita, et al.
Minerva Ginecologica|July 29, 2020
Clinicopathological effects of body composition measurements for patients with endometrial cancerChristopher G Smith, Deepti Sharma, Hagen Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2015
Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of SurvivalChristopher G Smith, David Fisher, Rebecca Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studiesSabine Venderbosch, Iris D Nagtegaal, Tim S Maughan, et al.
EMBO Molecular Medicine|June 1, 2018
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerDana Wai Yi Tsui, Muhammed Murtaza, Alvin Seng Cheong Wong, et al.
EMBO Molecular Medicine|July 22, 2021
Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patientsFlorent Mouliere, Christopher G Smith, Katrin Heider, et al.
Lancet (London, England)|June 7, 2011
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialTimothy S Maughan, Richard A Adams, Christopher G Smith, et al.
EMBO Molecular Medicine|May 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancerAngela Santonja, Wendy N Cooper, Matthew D Eldridge, et al.
NPJ Breast Cancer|July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapyJesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Science Advances|July 10, 2026
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencingHaichao Wang, Paulius D Mennea, Grainne McAndrew, et al.
Pageof 5